SABERTOOTH CAPITAL
SABERTOOTH CAPITAL is a Series C+ fund in global writing $5M–$50M checks into AI, Climate, Security, compute, space, defense, healthcare-tech and longevity.
- Stages
- Series C+
- Sectors
- AI, Climate, Security, compute, space, defense, healthcare-tech, longevity
- Check size
- $5M–$50M
- Invests in
- global
- Actively investing
- Yes
- Founded
- 2025
Thesis
Sabertooth Capital, founded in 2025 and based in Atlanta, Georgia, is a venture capital firm focused on investing in enduring technology companies that have the potential to reshape the global economy. Their investment thesis centers on identifying and backing foundational technologies. The firm's primary areas of interest include Artificial Intelligence (AI) and Compute, American Resilience (encompassing space, defense, and cybersecurity), Biological Horizons (advancements in health, cognition, and longevity), and Energy Frontiers (distributed energy storage, advanced nuclear, and next-generation power systems). Sabertooth Capital employs a concentrated, long-term investment strategy, aiming to intensely focus on ambitious entrepreneurs addressing critical global problems. They typically make investments ranging from $5 million to $50 million per deal. While specific AUM and fund sizes are not publicly disclosed, the firm's strategy suggests a focus on significant growth-stage technology companies. The firm was founded in 2025, with its legal name being Sabertooth Capital, and its headquarters in Atlanta, Georgia. It is important to note that "Sabertooth Capital" and "Sabertooth Ventures" appear to be distinct but related entities, with Sabertooth Capital focusing on venture investments and Sabertooth Ventures operating as a startup studio.
Common questions
Does SABERTOOTH CAPITAL invest at the Series C+ stage?
Yes. SABERTOOTH CAPITAL lists Series C+ among the stages it invests in.
What check size does SABERTOOTH CAPITAL write?
SABERTOOTH CAPITAL writes $5M–$50M checks.
Where does SABERTOOTH CAPITAL invest?
SABERTOOTH CAPITAL invests in global.